| Inhibitory Receptors in Eosinophils of Atopic Subjects (NCT01489293) | Meir Medical Center | 2012-05-01 |
| Study of Dupilumab in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis (NCT01548404) | Regeneron Pharmaceuticals | 2012-04-01 |
| Efficacy of Fluocinonide Cream 0.1% (Vanos(R)) in Reducing Itch in Subjects With Atopic Dermatitis (NCT01469767) | Wake Forest University | 2012-02-01 |
| A Study Evaluating the Safety and Efficacy of QGE031 in Atopic Dermatitis Patients (NCT01552629) | Novartis Pharmaceuticals | 2012-01-05 |
| A Phase 1, Randomized, Placebo-controlled, Dose-escalation Safety Study of MEDI4212 in Subjects With IgE >= 30 IU/mL (NCT01544348) | MedImmune LLC | 2012-01-01 |
| Atopy Patch Test in Children With Atopic Dermatitis (NCT02552979) | Mahidol University | 2012-01-01 |
| Effectiveness of Melatonin for Sleep Disturbances in Children With Atopic Dermatitis (NCT01638234) | National Taiwan University Hospital | 2012-01-01 |
| A Phase 2 Study of E6005 in Patients With Atopic Dermatitis (NCT01461941) | Organon and Co | 2011-12-01 |
| Probiotics and Allergic Diseases (NCT01635738) | GenMont Biotech Incorporation | 2011-12-01 |
| Effect of Oral Vitamin D Supplement on Atopic Dermatitis; A Clinical Trial With Staphylococcus Aureus Colonization Determination (NCT02058186) | Srinakharinwirot University | 2011-12-01 |
| S. Aureus Colonization in Atopic Dermatitis (NCT02091037) | Columbia University | 2011-12-01 |
| Twice Daily Versus Twice Weekly Soak-and-Seal Baths in Pediatric Atopic Dermatitis (NCT03397979) | MaineHealth | 2011-11-14 |
| Efficacy and Safety of a a Biofunctional Textile in the Management of Atopic Dermatitis (NCT01597817) | Universidade do Porto | 2011-11-01 |
| Prebiotics in Prevention of Atopy (NCT02116452) | Federico II University | 2011-11-01 |
| Atopic Dermatitis Research Network (ADRN) Influenza Vaccine Pilot (NCT01518478) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-11-01 |
| Effect of Pollen Challenges on Dermal Symptoms in Patients With Atopic Dermatitis (NCT01475994) | Fraunhofer-Institute of Toxicology and Experimental Medicine | 2011-11-01 |
| Efficacy Emollient on Xerosis in Children With Atopic Dermatitis (NCT01467362) | Pierre Fabre Medicament | 2011-11-01 |
| Sublingual Immunotherapy in Patients With Atopic Dermatitis (NCT01471119) | Zhejiang University | 2011-10-01 |
| Safety, Tolerability and Pharmacokinetics of LEO 29102 Cream in Atopic Dermatitis. (NCT01447758) | LEO Pharma | 2011-09-01 |
| Safety, Tolerability and Pharmacokinetic Study in Healthy Subjects by Dermal Application of a LEO 29102 (NCT01423656) | LEO Pharma | 2011-08-01 |
| Registry for the Atopic Dermatitis Research Network (NCT01494142) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-08-01 |
| Safety and Tolerability of Dupilumab in Participants With Moderate to Severe Atopic Dermatitis (NCT01385657) | Regeneron Pharmaceuticals | 2011-07-31 |
| HPA Axis Study in Adults (NCT01408511) | Bayer | 2011-07-19 |
| Evaluation of A-1 Cool Cream Efficacy for Treatment Atopic Dermatitis (NCT01174511) | Hadassah Medical Organization | 2011-07-01 |
| Eczema Action Plan Improves Patient and Caregiver Understanding and Perception of Atopic Dermatitis Management (NCT01660217) | Dermatology & Aesthetics of Wicker Park | 2011-06-01 |
| Pediatric Atopic Dermatitis (AD) Internet Survey (NCT01385527) | Wake Forest University | 2011-06-01 |
| Comparing Cetaphil Restoraderm System Versus Standard Skin Care in Infants (NCT01375205) | Oregon Health and Science University | 2011-06-01 |
| Clinical Importance of Filaggrin Gene Mutation for Treatment Outcome in Atopic Dermatitis (NCT01689805) | Helsinki University Central Hospital | 2011-06-01 |
| HPA Axis Study in Japanese Adults (NCT01407510) | Bayer | 2011-05-09 |
| Efficacy and Safety of Different Concentrations of Mapracorat Ointment Over 4 Weeks in Atopic Dermatitis (AD) (NCT01359787) | Bayer | 2011-05-01 |
| A Study Evaluating the Safety and Efficacy of Topical BPR277 for the Treatment of Atopic Dermatitis and Netherton Syndrome (NCT01428297) | Novartis Pharmaceuticals | 2011-05-01 |
| Narrow-band (NB)-UVB vs. Bath-PUVA and NB-UVB Plus Salt Water Baths in Atopic Dermatitis (NCT01402414) | Ruhr University of Bochum | 2011-04-01 |
| Interferon Responses in Eczema Herpeticum (NCT01429311) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-04-01 |
| Investigation of the Efficacy of 2.5% and 5% Cis-urocanic Acid in Patients With Moderate or Severe Atopic Dermatitis (NCT01320579) | BioCis Pharma Ltd | 2011-03-01 |
| Human Testing of an Over-the-Counter (OTC) Cream in Children With Eczema (NCT01326910) | Johnson & Johnson Consumer Products Company Division of Johnson & Johnson Consumer Companies, Inc. | 2011-03-01 |
| Cardiovascular Risk Assessment in Patients With Severe Psoriasis Treated With Biologic Agents (NCT01356758) | University of Aarhus | 2011-03-01 |
| Management of Eczema by Specific Probiotic Strains (NCT01230190) | Agentschap NL | 2011-03-01 |
| Skin Testing With Recombinant Bet v 1 and Hypoallergenic Recombinant Bet v 1 Fragments (NCT02098551) | Stefan Woehrl | 2011-02-01 |
| The Effects of Emollient Therapy on the Skin Barrier (NCT01291940) | Oregon Health and Science University | 2011-01-01 |
| Ciclosporin Versus Alitretinoin for Severe Atopic Hand Dermatitis. (NCT01231854) | Technische Universität Dresden | 2010-11-01 |
| Efficacy and Safety of Different Concentrations of ZK245186 in Atopic Dermatitis (AD) (NCT01228513) | Bayer | 2010-11-01 |
| Asthma, Missed Immunizations, and Vitamin D Deficiency in Atopic Dermatitis (NCT01234909) | Medical College of Wisconsin | 2010-11-01 |
| Chemokine Expression in Nummular Dermatitis and Atopic Dermatitis (NCT01311986) | National Taiwan University Hospital | 2010-11-01 |
| Safety, Efficacy and Pharmacokinetic Study of Allegra in Pediatric Patients With Atopic Dermatitis (AD) (NCT01244230) | Sanofi | 2010-11-01 |
| Vitamin D Deficiency and Atopic Dermatitis (NCT01337635) | Medical College of Wisconsin | 2010-11-01 |
| Safety Study Evaluating the Adrenal Suppression Potential of Product 0405 in Pediatric Subjects With Atopic Dermatitis (NCT01232543) | Fougera Pharmaceuticals Inc. | 2010-11-01 |
| Text Messaging and Atopic Dermatitis (NCT01216059) | Northwestern University | 2010-10-01 |
| Efficacy and Tolerability Study of Device, RD047-26 for the Treatment of Mild to Moderate Atopic Dermatitis in Adults (NCT01232985) | Oculus Innovative Sciences, Inc. | 2010-10-01 |
| Placebo Effect in the Treatment of Atopic Dermatitis (NCT02094287) | Margitta Worm | 2010-09-01 |
| A Study to Evaluate Safety, Tolerability and Efficacy of Lytixar™ (LTX-109) on Uncomplicated, Gram-positive, Skin Infection (NCT01223222) | Lytix Biopharma AS | 2010-09-01 |
| A Study of E6005 in Japanese Patients With Atopic Dermatitis (NCT01179880) | Organon and Co | 2010-09-01 |
| Reversal of Epidermal Phenotype in Severe Atopic Dermatitis With Cyclosporine Therapy (NCT01149759) | Rockefeller University | 2010-06-01 |
| Genetic Screening for Filaggrin Mutation in Atopic Dermatitis and Ichthyosis Vulgaris in the African American Population (NCT01016106) | Northwestern University | 2010-06-01 |
| Health Literacy for Children With Atopic Dermatitis and Their Caregivers (NCT01138761) | University of Missouri-Columbia | 2010-06-01 |
| A Pilot Study of Lactofiltrum to Treat Atopic Dermatitis in Adults (NCT01124318) | Avva Rus, JSC | 2010-05-01 |
| Cooling Pillow for Atopic Dermatitis (NCT01132651) | Northwestern University | 2010-05-01 |
| A Pilot Study Using Anakinra/Kineret for the Treatment of Patients With Severe Atopic Dermatitis (NCT01122914) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-04-14 |
| Bilateral Comparison Study of Elidel 1% and Hylatopic Plus Emollient Foam for the Treatment of Subjects With Atopic Dermatitis (NCT01202149) | Frankel, Amylynne, M.D. | 2010-03-01 |
| Safety and Efficacy Study of Altabax Ointment in the Treatment of Secondarily Infected Atopic Dermatitis (NCT01064947) | Derm Research, PLLC | 2010-02-01 |
| A Study to Investigate the Use of Hydrogel Vehicle in Maintaining the Skin Barrier in Persons With Atopic Dermatitis (NCT01065714) | Derm Research, PLLC | 2010-02-01 |
| Acupressure in Pruritus for Atopic Dermatitis (NCT01074164) | Northwestern University | 2010-02-01 |
| Analysis of the Quality of Life, the Clinical Effectiveness and Cost-effectiveness of a Novel Educational Programme in Patients With Psoriasis and Atopic Dermatitis (NCT01077882) | University Hospital, Ghent | 2010-01-01 |
| the Effectiveness of Probiotics on Atopic Dermatitis With Cow Milk Allergy (NCT01045486) | Soonchunhyang University Hospital | 2010-01-01 |
| LEO 29102 Cream in the Treatment of Atopic Dermatitis (NCT01037881) | LEO Pharma | 2009-12-01 |
| Sinecort Pilot Efficacy Study (NCT00980135) | Bayer | 2009-11-01 |
| A Safety, Tolerability and Pharmacokinetic Study of LEO 29102 in Subjects With Atopic Dermatitis (NCT01005823) | LEO Pharma | 2009-10-01 |
| Effect of Pimecrolimus Cream on Cathelicidin Levels in Subjects With Eczema (NCT00946478) | University of California, San Diego | 2009-10-01 |
| Comparison Between Asynchronous Online Care Model With Usual In Office Care for the Management of Atopic Dermatitis (NCT00985894) | University of California, Davis | 2009-09-01 |
| The Role of Topically Dissolved Oxygen (TDO) to Ameliorate Signs of Photodamage (NCT00991198) | Aria Aesthetics Inc. | 2009-09-01 |
| Pimecrolimus Cream 1% (Elidel®) and Medicated Device Cream (EletoneTM) in the Treatment and Maintenance of Atopic Dermatitis. (NCT01177566) | Emer, Jason, M.D. | 2009-09-01 |
| Assessment of the Phototoxic Potential of LEO 29102 Cream (NCT00958516) | LEO Pharma | 2009-09-01 |
| Comparing Aquaphor to Atopiclair and EpiCeram in Children With Mild to Moderate Atopic Dermatitis (NCT01093469) | Wake Forest University Health Sciences | 2009-09-01 |
| The Effectiveness of Montelukast on Atopic Dermatitis in Koreans (NCT00903357) | Pyun BokYang | 2009-08-01 |
| Dose Escalation of Different Concentrations of ZK 245186 in Atopic Dermatitis (NCT00944632) | Bayer | 2009-07-15 |
| A Study to Determine the Safety, Tolerability and Efficacy of KP-413 in Subjects With Atopic Dermatitis(AD) (NCT00932074) | Kaken Pharmaceutical | 2009-07-01 |
| Study of Apremilast in Atopic or Contact Dermatitis (NCT00931242) | Tufts Medical Center | 2009-06-01 |
| Climatotherapy At The Dead Sea For Atopic Dermatitis (NCT01307150) | Hadassah Medical Organization | 2009-06-01 |
| Effect of Galactooligosaccharides on Incidence of Atopic Manifestations in Infants (NCT02077088) | Humana Co.Ltd. | 2009-06-01 |
| Efficacy and Safety Study of CD2027 Ointment 3 Microgram Per Gram (mcg/g) Twice Daily Treatment for Adults With at Least Moderate Atopic Dermatitis (NCT00919763) | Galderma R&D | 2009-05-21 |
| Apremilast for Atopic Dermatitis - A Pilot Study in Adults (NCT01393158) | Oregon Health and Science University | 2009-05-01 |
| Impact of the Severity of Pediatric Psoriasis on Childhood Body Mass Index (NCT00879944) | Northwestern University | 2009-05-01 |
| To Evaluate the Safety and Efficacy of a New Device in the Management of Mild to Moderate Atopic Dermatitis in Children (NCT00886587) | Johnson & Johnson Consumer and Personal Products Worldwide | 2009-04-01 |
| Safety and Efficacy of SRD441 Ointment in Patients With Atopic Dermatitis (NCT00882245) | Serentis Ltd. | 2009-04-01 |
| A Study Evaluating the Efficacy of Fluocinonide Cream 0.1% (Vanos) in Subjects With Atopic Dermatitis (NCT01049243) | Wake Forest University Health Sciences | 2009-03-01 |
| LEO 29102 Single and Multiple Dose Study by Dermal Application (NCT00891709) | LEO Pharma | 2009-03-01 |
| Investigation of Efficacy and Safety of EPOGAM (NCT00878670) | Max Zeller Soehne AG | 2009-03-01 |
| Comparison of the Efficacy and Safety of Two Topical Creams for Pediatric Atopic Dermatitis (NCT00828412) | Promius Pharma, LLC | 2009-03-01 |
| The Underlying Mechanisms For S. Aureus Infection And Colonization Of Skin in People With Atopic Dermatitis With And Without Eczema Herpeticum (MRSA) (NCT00822276) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-02-01 |
| Exploratory Study of Natural Killer Cells in Human Skin (NCT00824889) | Assistance Publique Hopitaux De Marseille | 2009-02-01 |
| Vitamin D Supplementation in Childhood Atopic Dermatitis (NCT00879424) | Massachusetts General Hospital | 2009-02-01 |
| IDA (Immunothérapie de la Dermatite Atopique) Adult - Immunotherapy in Atopic Dermatitis (NCT00820820) | Institut National de la Santé Et de la Recherche Médicale, France | 2009-01-09 |
| Fractional Exhaled Nitric Oxide (FeNO) Result Prediction Factors in Children With Allergic Diseases (NCT00815984) | Medical University of Lodz | 2009-01-01 |
| Tolerance and Efficacy of Formulation 609580 20 Versus Formulation 609209 in Children With Atopic Dermatitis (NCT00931411) | Cosmetique Active International | 2009-01-01 |
| VANOS Cream and Skin Barrier Function (NCT00819507) | Oregon Health and Science University | 2009-01-01 |
| Comparison of Video-Based Versus Written Patient Education on Atopic Dermatitis (NCT00826592) | University of California, Davis | 2009-01-01 |
| Probiotics and Breastmilk Decrease Risk of Atopic Dermatitis in Premature Infants (NCT06035835) | José Uberos Fernández | 2009-01-01 |
| A Study of BRT-FC-83C for the Treatment of Atopic Dermatitis (NCT00883311) | Biomed Research & Technologies, Inc. | 2009-01-01 |
| Analysis of Response of Subjects With Atopic Dermatitis or Psoriasis to Oral Vitamin D3 (NCT00789880) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-12-01 |
| Study of Methotrexate Efficacy Versus Cyclosporine in Moderate to Severe Atopic Dermatitis Patients (NCT00809172) | Hospices Civils de Lyon | 2008-12-01 |
| Bronchial Hyperreactivity in Atopic Dermatitis Patients - a 10 Year Follow-up (NCT00795496) | University of Helsinki | 2008-11-01 |